A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine.

Masoudi M, Seki M, Yazdanparast R, Yachie N, Aburatani H.Sci Rep. 2019 12 16;9(1):19188. doi: 10.1038/s41598-019-55893-2